Biorestorative Therapies (BRTX)
(Delayed Data from NSDQ)
$1.38 USD
+0.01 (0.73%)
Updated May 16, 2024 04:00 PM ET
After-Market: $1.34 -0.04 (-2.90%) 4:38 PM ET
2-Buy of 5 2
F Value C Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/14/2024
Time: AMC |
3/2024 | $-0.51 | 0.00% |
Earnings Summary
For their last quarter, Biorestorative Therapies (BRTX) reported earnings of -$0.57 per share, beating the Zacks Consensus Estimate of $-0.65 per share. This reflects a positive earnings surprise of 12.31%. Look out for BRTX's next earnings release on May 14, 2024. For the next earning release, we expect the company to report earnings of -$0.51 per share, reflecting a year-over-year increase of 66.67%.
Earnings History
Price & Consensus
Zacks News for BRTX
Y-mAbs Therapeutics, Inc. (YMAB) Reports Q2 Loss, Tops Revenue Estimates
BRTX: What are Zacks experts saying now?
Zacks Private Portfolio Services